553 results on '"Tabrizi, Sarah J."'
Search Results
2. Prognostic enrichment for early-stage Huntington’s disease: An explainable machine learning approach for clinical trial
3. Forecasting individual progression trajectories in Huntington disease enables more powered clinical trials
4. Lumbar puncture safety and tolerability in premanifest and manifest Huntington’s disease: a multi-analysis cross-sectional study
5. Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues
6. Huntington disease alters the actionable information in plasma extracellular vesicles
7. FAN1 controls mismatch repair complex assembly via MLH1 retention to stabilize CAG repeat expansion in Huntington’s disease
8. KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients
9. Genetic testing in dementia — utility and clinical strategies
10. Complementary insights into corticostriatal synapse loss and cognition in Huntington’s disease
11. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
12. Human Huntington’s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species
13. The human motor cortex microcircuit: insights for neurodegenerative disease
14. Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease
15. Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington’s disease
16. Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration
17. Mutant huntingtin impairs immune cell migration in Huntington disease
18. Wild-type huntingtin regulates human macrophage function
19. Can MSH3 lowering stop HTT repeat expansion in its CAG tract?
20. Progressive alterations in white matter microstructure across the timecourse of Huntington's disease
21. A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod
22. Reply to ‘Topographical layer imaging as a tool to track neurodegenerative disease spread in M1’
23. Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment
24. Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington's disease.
25. Inflammatory markers in Huntington's disease plasma—A robust nanoLC–MRM-MS assay development
26. Stimulating neural plasticity with real‐time fMRI neurofeedback in Huntingtonʼs disease: A proof of concept study
27. In vivo neutralization of the protagonist role of macrophages during the chronic inflammatory stage of Huntington’s disease
28. Neurofilament light-associated connectivity in young-adult Huntington’s disease is related to neuronal genes
29. Additional file 22 of Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissues
30. Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients
31. Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
32. Huntington's disease
33. Analysis of Potential Transcriptomic Biomarkers for Huntington's Disease in Peripheral Blood
34. Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington’s disease
35. Large-scale brain network abnormalities in Huntingtonʼs disease revealed by structural covariance
36. Intellectual enrichment and genetic modifiers of cognition and brain volume in Huntington's disease.
37. Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington’s disease
38. Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease
39. Mislocalization of Nucleocytoplasmic Transport Proteins in Human Huntington’s Disease PSC-Derived Striatal Neurons
40. A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington’s Disease
41. Relating quantitative 7T MRI across cortical depths to cytoarchitectonics, gene expression and connectomics
42. MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1
43. Task-specific training in Huntington disease: a randomized controlled feasibility trial
44. Basal ganglia-cortical structural connectivity in Huntingtonʼs disease
45. An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntingtonʼs disease
46. FAN1 modifies Huntington’s disease progression by stabilizing the expanded HTT CAG repeat
47. Additional file 1 of Human Huntington’s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species
48. Additional file 2 of Human Huntington’s disease pluripotent stem cell-derived microglia develop normally but are abnormally hyper-reactive and release elevated levels of reactive oxygen species
49. Peripheral inflammation in neurodegeneration
50. Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.